CLINICAL_TRIALS
trial_result
· 2025-01-20
Clinical Trial Update: Open-label Multi-site Extension Trial in Subjects Who Completed the DELTA 1 or DELTA 2 Trials [Phase 3]
Summary
Open-label, multi-site extension study in Chronic Hand Eczema patients who completed the DELTA 1 or DELTA 2 Phase 3 trials; results were posted on 2025-01-20.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: LEO Pharma | Conditions: Chronic Hand Eczema | Phase 3 | Status: COMPLETED | Results posted: 2025-01-20